Product Information
DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.7632 per EA under NDC 31722023401. Its NADAC has been published 220 times since Jun 8, 2022.
FDA first approved this application on Dec 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722023401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215523FDA Approved
12/8/2021
TE Code
AB
On Market Since
12/8/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 220 times since Jun 8, 2022, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7632 per EA |
|---|---|
| All-time high | $2.4994 (Nov 13, 2024) |
| All-time low | $0.7499 (May 22, 2024) |
| 52-week high | $2.0211 |
| 52-week low | $1.4839 |
| Median price | $1.7121 |
| Average price | $1.6751 |
| Largest weekly change | +75.7% (Jun 19, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Camber Pharmaceuticals Inc., is $1.7632 per EA (NDC 31722023401), effective Aug 19, 2026.
How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has risen 7.8%. It has been tracked across 220 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?
Since Jun 8, 2022, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $0.7499 (May 22, 2024) to a high of $2.4994 (Nov 13, 2024), with a median of $1.7121 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?
DEXMETHYLPHENIDATE ER 30 MG CP (NDC 31722023401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.